• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参考定价与企业定价策略。

Reference pricing and firms' pricing strategies.

作者信息

Miraldo Marisa

机构信息

Imperial College Business School, Imperial College, London, UK.

出版信息

J Health Econ. 2009 Jan;28(1):176-97. doi: 10.1016/j.jhealeco.2008.09.006. Epub 2008 Oct 4.

DOI:10.1016/j.jhealeco.2008.09.006
PMID:19038465
Abstract

Within a horizontal differentiation model and allowing for heterogeneous qualities, we analyze the effects of reference pricing reimbursement on firms' pricing strategies. With this analysis we find inherent incentives for firms' pricing behavior, and consequently we shed some light on the time consistency of such policy. The analysis encompasses different reference price rules: (i) reference price as the minimum of the observed prices in the market, (ii) reference price as a linear combination of firms' prices. Results show that under the "minimum policy" firms are not able to coordinate on higher prices while the "linear policy", implicitly, provides a coordination device. We have also found that, relatively to the "linear policy", when the reference price is the minimum of observed prices, after policy implementation, total and private expenditures are higher and consumer surplus and firms' profits are lower. With quality differentiation both the minimum and linear policies unambiguously lead to higher prices.

摘要

在一个水平差异化模型中,并考虑到产品质量的异质性,我们分析了参考定价报销对企业定价策略的影响。通过这一分析,我们发现了企业定价行为的内在激励因素,从而对该政策的时间一致性有了一定的了解。该分析涵盖了不同的参考价格规则:(i)参考价格为市场上观察到的最低价格,(ii)参考价格为企业价格的线性组合。结果表明,在“最低政策”下,企业无法就更高的价格进行协调,而“线性政策”则隐含地提供了一种协调机制。我们还发现,相对于“线性政策”,当参考价格为观察到的最低价格时,政策实施后,总支出和私人支出会更高,消费者剩余和企业利润会更低。在存在质量差异的情况下,最低政策和线性政策都会明确导致更高的价格。

相似文献

1
Reference pricing and firms' pricing strategies.参考定价与企业定价策略。
J Health Econ. 2009 Jan;28(1):176-97. doi: 10.1016/j.jhealeco.2008.09.006. Epub 2008 Oct 4.
2
Reference pricing of pharmaceuticals.药品参考定价
J Health Econ. 2007 May 1;26(3):613-42. doi: 10.1016/j.jhealeco.2006.11.003. Epub 2006 Dec 22.
3
Competition and the Reference Pricing Scheme for pharmaceuticals.药品竞争与参考定价机制。
J Health Econ. 2011 Dec;30(6):1137-49. doi: 10.1016/j.jhealeco.2011.08.010. Epub 2011 Sep 3.
4
Impact of cross-reference pricing on pharmaceutical prices: manufacturers' pricing strategies and price regulation.交叉参考定价对药品价格的影响:制造商的定价策略与价格监管
Appl Health Econ Health Policy. 2006;5(4):235-47. doi: 10.2165/00148365-200605040-00005.
5
[Pharmaceutical reference pricing in Germany: definition of therapeutic groups, price setting through regression procedure and effects].[德国的药品参考定价:治疗组的定义、通过回归程序设定价格及效果]
Gesundheitswesen. 2005 Jul;67(7):468-77. doi: 10.1055/s-2005-858485.
6
Effects of the German reference drug program on ex-factory prices of prescription drugs: a panel data approach.德国参考药物计划对处方药出厂价格的影响:一种面板数据方法。
Health Econ. 2009 Apr;18(4):421-36. doi: 10.1002/hec.1376.
7
The strategic interaction between firms and formulary committees: effects on the prices of new drugs.企业与药品处方集委员会之间的战略互动:对新药价格的影响。
J Health Econ. 2008 Mar;27(2):377-404. doi: 10.1016/j.jhealeco.2007.06.003. Epub 2007 Dec 3.
8
Differences in external price referencing in Europe: a descriptive overview.欧洲外部价格参照的差异:描述性概述。
Health Policy. 2012 Jan;104(1):50-60. doi: 10.1016/j.healthpol.2011.09.008. Epub 2011 Oct 19.
9
Pharmaceutical pricing and reimbursement reforms in Greece.希腊的药品定价与报销改革。
Eur J Health Econ. 2008 Feb;9(1):87-97. doi: 10.1007/s10198-007-0061-6.
10
Implications of external price referencing of pharmaceuticals in Middle East countries.中东国家药品外部价格参考的影响
Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):993-8. doi: 10.1586/14737167.2015.1048227. Epub 2015 Jun 18.

引用本文的文献

1
Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs' reimbursements.内部参考定价体系中的药品定价动态:来自药品报销变化的证据。
Eur J Health Econ. 2022 Dec;23(9):1497-1518. doi: 10.1007/s10198-022-01440-2. Epub 2022 Feb 22.
2
Factors influencing pharmaceutical pricing - a scoping review of academic literature in health science.影响药品定价的因素——健康科学领域学术文献的范围综述
J Pharm Policy Pract. 2019 Jun 27;12:24. doi: 10.1186/s40545-019-0183-0. eCollection 2019.
3
A simulation model to evaluate pharmaceutical supply chain costs in hospitals: the case of a Colombian hospital.
评估医院药品供应链成本的仿真模型:以一家哥伦比亚医院为例。
Daru. 2020 Jun;28(1):1-12. doi: 10.1007/s40199-018-0218-0. Epub 2018 Dec 18.
4
Comprehensive taxonomy and worldwide trends in pharmaceutical policies in relation to country income status.与国家收入状况相关的制药政策的综合分类及全球趋势。
BMC Health Serv Res. 2017 May 25;17(1):371. doi: 10.1186/s12913-017-2304-2.
5
Endogenous versus exogenous generic reference pricing for pharmaceuticals.药品的内源性与外源性仿制药参考定价
Int J Health Econ Manag. 2017 Dec;17(4):413-432. doi: 10.1007/s10754-017-9216-x. Epub 2017 May 15.
6
Reference pricing in the presence of pseudo-generics.存在伪仿制药情况下的参考定价
Int J Health Econ Manag. 2015 Sep;15(3):281-305. doi: 10.1007/s10754-015-9165-1. Epub 2015 Feb 1.
7
Reference Pricing with Endogenous or Exogenous Payment Limits: Impacts on Insurer and Consumer Spending.具有内生或外生支付限制的参考定价:对保险公司和消费者支出的影响。
Health Econ. 2016 Jun;25(6):740-9. doi: 10.1002/hec.3181. Epub 2015 Apr 22.
8
Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?平行进口与强制替代改革:对药品价格竞争是助力还是阻碍?
Eur J Health Econ. 2015 Dec;16(9):969-83. doi: 10.1007/s10198-014-0646-9. Epub 2014 Nov 18.
9
Compulsory licensing and access to drugs.强制许可和药品获取。
Eur J Health Econ. 2015 Jan;16(1):83-94. doi: 10.1007/s10198-013-0556-2. Epub 2014 Jan 10.
10
The effects of rebate contracts on the health care system.回扣合同对医疗保健系统的影响。
Eur J Health Econ. 2014 Jun;15(5):477-87. doi: 10.1007/s10198-013-0488-x. Epub 2013 Jun 23.